| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/22/2023 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Stock Option (right to buy) | 2M | $0.30 | $585k | | 06/22/2023 |
| 06/28/2022 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 20k | $1.21 | $24.2k | | 06/28/2022 |
| 06/07/2022 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Director Stock Option (right to buy) | 43k | $0.73 | $31.4k | | 06/07/2022 |
| 06/06/2022 | X4 Pharmaceuticals, Inc | XFOR | Grant | Common Stock | 6.7k | $0.00 | $0 | | 06/06/2022 |
| 06/08/2021 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Director Stock Option (right to buy) | 40k | $6.80 | $272k | | 06/08/2021 |
| 06/02/2021 | X4 Pharmaceuticals, Inc | XFOR | Grant | Stock Option (right to buy) | 6k | $9.50 | $57k | | 06/02/2021 |
| 06/01/2021 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 18.2k | $12.91 | $234.8k | | 06/01/2021 |
| 12/22/2020 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 36.4k | $7.85 | $285.6k | | 12/22/2020 |
| 12/15/2020 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Director Stock Option (right to buy) | 47.2k | $9.09 | $429k | | 12/15/2020 |
| 10/05/2020 | X4 Pharmaceuticals, Inc | XFOR | Grant | Stock Option (right to buy) | 6.9k | $7.33 | $50.2k | | 10/05/2020 |
| 04/15/2020 | Kaleido Biosciences, Inc. | KLDO | Grant | Stock Option (Right to Buy) | 118.5k | $6.00 | $711k | | 04/15/2020 |
| 02/28/2020 | Kaleido Biosciences, Inc. | KLDO | Grant | Restricted Stock Units | 46.3k | $0.00 | $0 | | 02/28/2020 |
| 11/15/2019 | Kaleido Biosciences, Inc. | KLDO | Grant | Stock Option (Right to Buy) | 150k | $6.56 | $984k | | 11/15/2019 |
| 03/04/2019 | Kaleido Biosciences, Inc. | KLDO | Grant | Stock Option (Right to Buy) | 150k | $15.00 | $2.2M | | 03/04/2019 |
| 06/13/2017 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 25k | $2.09 | $52.2k | | 06/13/2017 |
| 03/01/2017 | CoLucid Pharmaceuticals, Inc. | CLCD | Disposition | Stock Option (Right to Buy) | 1.4k | $6.54 | $9.3k | | 03/01/2017 |
| 03/01/2017 | CoLucid Pharmaceuticals, Inc. | CLCD | Disposition | Stock Option (Right to Buy) | 8.9k | $6.24 | $55.5k | | 03/01/2017 |
| 03/01/2017 | CoLucid Pharmaceuticals, Inc. | CLCD | Disposition | Stock Option (Right to Buy) | 658 | $36.20 | $23.8k | | 03/01/2017 |
| 06/14/2016 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 25k | $1.37 | $34.2k | | 06/14/2016 |
| 05/10/2016 | CoLucid Pharmaceuticals, Inc. | CLCD | Grant | Stock Option (Right to Buy) | 8.9k | $6.24 | $55.5k | | 05/10/2016 |
| 06/07/2013 | Tempest Therapeutics, Inc. | OVAS | Grant | Stock Option (right to buy) | 100.3k | $14.00 | $1.4M | | 06/07/2013 |
| 06/06/2013 | CUBIST PHARMACEUTICALS INC | CBST | Exercise | Restricted Stock Units | 1.3k | $0.00 | $0 | | 06/06/2013 |
| 03/07/2013 | Tempest Therapeutics, Inc. | OVAS | Grant | Stock Option (right to buy) | 368.9k | $13.50 | $5M | | 03/07/2013 |
| 11/26/2012 | Verastem, Inc. | VSTM | Grant | Stock Option (Right to Buy) | 25k | $6.47 | $161.8k | | 11/26/2012 |
| 02/15/2012 | CUBIST PHARMACEUTICALS INC | CBST | Grant | Stock Options (Right to Buy) | 10.8k | $40.59 | $440.1k | | 02/15/2012 |